Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma. Target Oncol. 2012 Sep; 7(3):199-210.

View in: PubMed

subject areas

Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Humans
Lung Neoplasms
Lymphoma, Non-Hodgkin
Models, Genetic
Mutation
Neuroblastoma
Oncogene Proteins, Fusion
Pyrazoles
Pyridines
Receptor Protein-Tyrosine Kinases
Signal Transduction
Translocation, Genetic

authors with profiles

Ravi Salgia
Susan L. Cohn